Logo image of CCEP.AS

COCA-COLA EUROPACIFIC PARTNE (CCEP.AS) Stock Fundamental Analysis

Europe - AMS:CCEP - GB00BDCPN049 - Common Stock

75.9 EUR
-0.7 (-0.91%)
Last: 9/15/2025, 4:52:02 PM
Fundamental Rating

4

CCEP gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 27 industry peers in the Beverages industry. CCEP has a medium profitability rating, but doesn't score so well on its financial health evaluation. CCEP is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year CCEP was profitable.
In the past year CCEP had a positive cash flow from operations.
In the past 5 years CCEP has always been profitable.
Each year in the past 5 years CCEP had a positive operating cash flow.
CCEP.AS Yearly Net Income VS EBIT VS OCF VS FCFCCEP.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

1.2 Ratios

CCEP has a better Return On Assets (4.83%) than 74.07% of its industry peers.
CCEP's Return On Equity of 19.11% is fine compared to the rest of the industry. CCEP outperforms 77.78% of its industry peers.
The Return On Invested Capital of CCEP (7.78%) is better than 62.96% of its industry peers.
CCEP had an Average Return On Invested Capital over the past 3 years of 7.84%. This is in line with the industry average of 8.63%.
Industry RankSector Rank
ROA 4.83%
ROE 19.11%
ROIC 7.78%
ROA(3y)5.14%
ROA(5y)4.27%
ROE(3y)19.29%
ROE(5y)16.02%
ROIC(3y)7.84%
ROIC(5y)6.6%
CCEP.AS Yearly ROA, ROE, ROICCCEP.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

1.3 Margins

CCEP's Profit Margin of 7.35% is in line compared to the rest of the industry. CCEP outperforms 44.44% of its industry peers.
CCEP's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 11.13%, CCEP is doing worse than 74.07% of the companies in the same industry.
CCEP's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 35.20%, CCEP is doing worse than 85.19% of the companies in the same industry.
In the last couple of years the Gross Margin of CCEP has remained more or less at the same level.
Industry RankSector Rank
OM 11.13%
PM (TTM) 7.35%
GM 35.2%
OM growth 3Y1.73%
OM growth 5Y-1.57%
PM growth 3Y-0.93%
PM growth 5Y-5.22%
GM growth 3Y-1.58%
GM growth 5Y-1.5%
CCEP.AS Yearly Profit, Operating, Gross MarginsCCEP.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CCEP is still creating some value.
The number of shares outstanding for CCEP has been increased compared to 1 year ago.
The number of shares outstanding for CCEP has been increased compared to 5 years ago.
The debt/assets ratio for CCEP has been reduced compared to a year ago.
CCEP.AS Yearly Shares OutstandingCCEP.AS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M
CCEP.AS Yearly Total Debt VS Total AssetsCCEP.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

CCEP has an Altman-Z score of 2.06. This is not the best score and indicates that CCEP is in the grey zone with still only limited risk for bankruptcy at the moment.
The Altman-Z score of CCEP (2.06) is comparable to the rest of the industry.
CCEP has a debt to FCF ratio of 6.04. This is a slightly negative value and a sign of low solvency as CCEP would need 6.04 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 6.04, CCEP belongs to the top of the industry, outperforming 81.48% of the companies in the same industry.
A Debt/Equity ratio of 1.26 is on the high side and indicates that CCEP has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 1.26, CCEP is doing worse than 62.96% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.26
Debt/FCF 6.04
Altman-Z 2.06
ROIC/WACC1.06
WACC7.37%
CCEP.AS Yearly LT Debt VS Equity VS FCFCCEP.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.3 Liquidity

CCEP has a Current Ratio of 0.83. This is a bad value and indicates that CCEP is not financially healthy enough and could expect problems in meeting its short term obligations.
CCEP's Current ratio of 0.83 is on the low side compared to the rest of the industry. CCEP is outperformed by 66.67% of its industry peers.
A Quick Ratio of 0.65 indicates that CCEP may have some problems paying its short term obligations.
CCEP's Quick ratio of 0.65 is in line compared to the rest of the industry. CCEP outperforms 55.56% of its industry peers.
Industry RankSector Rank
Current Ratio 0.83
Quick Ratio 0.65
CCEP.AS Yearly Current Assets VS Current LiabilitesCCEP.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

5

3. Growth

3.1 Past

The earnings per share for CCEP have decreased by -4.76% in the last year.
Measured over the past 5 years, CCEP shows a small growth in Earnings Per Share. The EPS has been growing by 5.80% on average per year.
CCEP shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 9.04%.
Measured over the past years, CCEP shows a quite strong growth in Revenue. The Revenue has been growing by 11.21% on average per year.
EPS 1Y (TTM)-4.76%
EPS 3Y12.68%
EPS 5Y5.8%
EPS Q2Q%14.98%
Revenue 1Y (TTM)9.04%
Revenue growth 3Y14.09%
Revenue growth 5Y11.21%
Sales Q2Q%4.54%

3.2 Future

The Earnings Per Share is expected to grow by 9.37% on average over the next years. This is quite good.
The Revenue is expected to grow by 3.62% on average over the next years.
EPS Next Y5.02%
EPS Next 2Y6.8%
EPS Next 3Y7.56%
EPS Next 5Y9.37%
Revenue Next Year2.4%
Revenue Next 2Y2.7%
Revenue Next 3Y3.1%
Revenue Next 5Y3.62%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CCEP.AS Yearly Revenue VS EstimatesCCEP.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5B 10B 15B 20B 25B
CCEP.AS Yearly EPS VS EstimatesCCEP.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6

3

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 22.79 indicates a rather expensive valuation of CCEP.
Compared to the rest of the industry, the Price/Earnings ratio of CCEP is on the same level as its industry peers.
Compared to an average S&P500 Price/Earnings ratio of 27.30, CCEP is valued at the same level.
With a Price/Forward Earnings ratio of 16.61, CCEP is valued correctly.
The rest of the industry has a similar Price/Forward Earnings ratio as CCEP.
CCEP is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.73, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 22.79
Fwd PE 16.61
CCEP.AS Price Earnings VS Forward Price EarningsCCEP.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CCEP is valued a bit more expensive than the industry average as 70.37% of the companies are valued more cheaply.
62.96% of the companies in the same industry are more expensive than CCEP, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 17.41
EV/EBITDA 13.46
CCEP.AS Per share dataCCEP.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates CCEP does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)4.54
PEG (5Y)3.93
EPS Next 2Y6.8%
EPS Next 3Y7.56%

3

5. Dividend

5.1 Amount

CCEP has a Yearly Dividend Yield of 2.49%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 2.85, CCEP has a dividend in line with its industry peers.
CCEP's Dividend Yield is comparable with the S&P500 average which is at 2.38.
Industry RankSector Rank
Dividend Yield 2.49%

5.2 History

The dividend of CCEP is nicely growing with an annual growth rate of 9.91%!
Dividend Growth(5Y)9.91%
Div Incr Years4
Div Non Decr Years4
CCEP.AS Yearly Dividends per shareCCEP.AS Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

CCEP pays out 60.89% of its income as dividend. This is not a sustainable payout ratio.
CCEP's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP60.89%
EPS Next 2Y6.8%
EPS Next 3Y7.56%
CCEP.AS Yearly Income VS Free CF VS DividendCCEP.AS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B
CCEP.AS Dividend Payout.CCEP.AS Dividend Payout, showing the Payout Ratio.CCEP.AS Dividend Payout.PayoutRetained Earnings

COCA-COLA EUROPACIFIC PARTNE

AMS:CCEP (9/15/2025, 4:52:02 PM)

75.9

-0.7 (-0.91%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryBeverages
Earnings (Last)08-06 2025-08-06/bmo
Earnings (Next)11-05 2025-11-05
Inst Owners38%
Inst Owner ChangeN/A
Ins Owners0.22%
Ins Owner ChangeN/A
Market Cap34.62B
Analysts77.27
Price Target86.93 (14.53%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.49%
Yearly Dividend1.98
Dividend Growth(5Y)9.91%
DP60.89%
Div Incr Years4
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.47%
PT rev (3m)2.49%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-0.39%
EPS NY rev (3m)-0.45%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.61%
Revenue NY rev (3m)-0.81%
Valuation
Industry RankSector Rank
PE 22.79
Fwd PE 16.61
P/S 1.66
P/FCF 17.41
P/OCF 11.83
P/B 4.31
P/tB N/A
EV/EBITDA 13.46
EPS(TTM)3.33
EY4.39%
EPS(NY)4.57
Fwd EY6.02%
FCF(TTM)4.36
FCFY5.74%
OCF(TTM)6.41
OCFY8.45%
SpS45.79
BVpS17.6
TBVpS-19.62
PEG (NY)4.54
PEG (5Y)3.93
Profitability
Industry RankSector Rank
ROA 4.83%
ROE 19.11%
ROCE 10.52%
ROIC 7.78%
ROICexc 8.57%
ROICexgc 51.16%
OM 11.13%
PM (TTM) 7.35%
GM 35.2%
FCFM 9.52%
ROA(3y)5.14%
ROA(5y)4.27%
ROE(3y)19.29%
ROE(5y)16.02%
ROIC(3y)7.84%
ROIC(5y)6.6%
ROICexc(3y)8.71%
ROICexc(5y)7.37%
ROICexgc(3y)64.53%
ROICexgc(5y)51.3%
ROCE(3y)10.42%
ROCE(5y)8.8%
ROICexcg growth 3Y8.99%
ROICexcg growth 5Y7.35%
ROICexc growth 3Y14.53%
ROICexc growth 5Y1.38%
OM growth 3Y1.73%
OM growth 5Y-1.57%
PM growth 3Y-0.93%
PM growth 5Y-5.22%
GM growth 3Y-1.58%
GM growth 5Y-1.5%
F-Score6
Asset Turnover0.66
Health
Industry RankSector Rank
Debt/Equity 1.26
Debt/FCF 6.04
Debt/EBITDA 3.08
Cap/Depr 98.22%
Cap/Sales 4.49%
Interest Coverage 9.37
Cash Conversion 89.23%
Profit Quality 129.6%
Current Ratio 0.83
Quick Ratio 0.65
Altman-Z 2.06
F-Score6
WACC7.37%
ROIC/WACC1.06
Cap/Depr(3y)92.36%
Cap/Depr(5y)78.04%
Cap/Sales(3y)4.17%
Cap/Sales(5y)3.92%
Profit Quality(3y)141.19%
Profit Quality(5y)162.2%
High Growth Momentum
Growth
EPS 1Y (TTM)-4.76%
EPS 3Y12.68%
EPS 5Y5.8%
EPS Q2Q%14.98%
EPS Next Y5.02%
EPS Next 2Y6.8%
EPS Next 3Y7.56%
EPS Next 5Y9.37%
Revenue 1Y (TTM)9.04%
Revenue growth 3Y14.09%
Revenue growth 5Y11.21%
Sales Q2Q%4.54%
Revenue Next Year2.4%
Revenue Next 2Y2.7%
Revenue Next 3Y3.1%
Revenue Next 5Y3.62%
EBIT growth 1Y2.97%
EBIT growth 3Y16.06%
EBIT growth 5Y9.46%
EBIT Next Year42.14%
EBIT Next 3Y17.33%
EBIT Next 5Y12.26%
FCF growth 1Y5.8%
FCF growth 3Y8.29%
FCF growth 5Y10.26%
OCF growth 1Y13.11%
OCF growth 3Y13.08%
OCF growth 5Y9.96%